文献速递关节外科

假体周围膝关节感染行清创、抗生素及假体保留治疗的满意成功率

Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention.
PubMed 文献 · J Arthroplasty · 2018-10-09

该回顾性队列研究纳入58例初次全膝关节置换术后急性假体周围关节感染并接受清创、抗生素及假体保留(DAIR)治疗的患者,至少随访2年。DAIR总体成功率为84%,初次手术后28天内、42天内和90天后翻修者的成功率分别为85%、88%和60%;90天内翻修者成功率90%(43/48),与病原体无关。作者认为早期DAIR并辅以相关翻修后抗生素方案是可行且安全的选择。

要点

  • DAIR治疗初次全膝关节置换术后假体周围关节感染的总体成功率为84%。
  • 初次手术后28天内、42天内和90天后翻修者的成功率分别为85%、88%和60%。
  • 90天内翻修者成功率为90%(43/48),与分离微生物类型无关。

核心结论

  • 作者认为,在初次手术后早期进行DAIR并辅以相关的翻修后抗生素方案,是治疗初次全膝关节置换术后假体周围关节感染的可行且安全的选择。

研究设计与样本

  • 回顾性队列研究,纳入67例初次全膝关节置换术后假体周围关节感染并接受DAIR的患者,排除数据不足及不符合肌肉骨骼感染学会(MSIS)假体周围关节感染标准者后,58例纳入分析,最短随访2年。

主要发现

  • DAIR治疗假体周围关节感染的总体成功率为84%。
  • 至DAIR的中位时间为21天(范围7-1092天)。
  • 34例(59%)在28天内翻修,42例(72%)在42天内翻修,10例(17%)在初次全膝关节置换术后超过90天翻修。
  • 上述三组成功率分别为85%、88%和60%。
  • 90天内翻修的患者成功率为90%(43/48),与所涉及的微生物无关。

关键数值与推荐

  • DAIR成功定义为患者2年后无感染。
  • 患者需符合肌肉骨骼感染学会(MSIS)假体周围关节感染标准。

临床怎么用

  • 作者认为,对于初次全膝关节置换术后假体周围关节感染,在初次手术后早期进行DAIR并辅以相关的翻修后抗生素方案是可行且安全的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute periprosthetic joint infection (PJI) following primary total knee arthroplasty (TKA) surgery can be treated with debridement, antibiotics, and implant retention (DAIR). However, varying results have been reported in the literature and optimal timing of the procedure is still debated. In this retrospective cohort study, we investigate (a) success rate of DAIR for treating PJI following primary TKA surgery and (b) whether time after primary surgery until DAIR and (c) type of isolated microorganism influence outcome. METHODS: Sixty-seven patients with PJI following primary TKA surgery treated with DAIR were identified. Patients with insufficient data and patients who did not fulfill Musculoskeletal Infection Society PJI criteria were excluded, leaving 58 patients for analysis. Minimum follow-up was 2 years. A DAIR was considered a success if the patient was infection free after 2 years. RESULTS: The overall success rate of PJI treated with DAIR was 84%. Median time until DAIR was 21 days (7-1092). Thirty-four patients (59%) were revised within 28 days, 42 patients (72%) within 42 days, while 10 patients (17%) were revised more than 90 days after primary TKA surgery. The success rates were 85%, 88%, and 60%, respectively. In the patients revised within 90 days, our success rate was 90% (43/48) regardless of the involved microorganism. CONCLUSION: We find DAIR to be a viable and safe treatment option for PJI following primary TKA surgery, when performed early after primary surgery and with the addition of a relevant postrevision antibiotic regime.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ottesen CS, Troelsen A, Sandholdt H, et al. Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention. J Arthroplasty. 2018. PMID: 30401558. doi:10.1016/j.arth.2018.09.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。